Lymphoma in Patients with Rheumatoid Arthritis
Lymphoma in Patients with Rheumatoid Arthritis
复制标题
类风湿关节炎患者的淋巴瘤
DOI:
10.2165/00002018-199920060-00002
复制
发表时间:
1999
期刊:
影响因子:
4.2
通讯作者:
S. Paget
中科院分区:
文献类型:
--
作者:
L. Georgescu;S. Paget
An increasing number of instances of lymphoma in patients with rheumatoid arthritis who are treated with methotrexate continue to appear. The majority of patients with lymphoproliferation have features of immunosuppression-associated lymphoma. Rheumatoid arthritis itself and the actions of methotrexate concur in leading to a immunosuppressed state.Possible oncogenic mechanisms and the risk factors for patients with rheumatoid arthritis to develop lymphoma while receiving methotrexate include: (i) intense immunosuppression and severe disease in combination with genetic predisposition and; (ii) an increased frequency of latent infection with pro-oncogenic viruses like Epstein-Barr virus.The aetiological role of methotrexate in the development of these lymphomas is supported by the spontaneous remission of these malignancies in some of patients with rheumatoid arthritis after methotrexate has been stopped. The physicians caring for patients with rheumatoid arthritis receiving methotrexate should be vigilant about signs and symptoms suggestive of lymphoma, mostly in those patients with significant comorbidity, long standing and severe disease who are more likely to be immunosuppressed. If a lymphoma appears in these patients, methotrexate should be stopped.Spontaneous remission may occur and a period of observation is advisable when clinically possible. If functional deterioration appears or there are signs of lymphoproliferative organ invasion after several months then specific antineoplastic treatment should be instituted.
登录
查看更多内容
DOI:
10.1016/0002-9343(85)90312-2
发表时间:
1985
期刊:
The American journal of medicine
影响因子:
--
作者:
Weinstein,A;Marlowe,S;Korn,J;Farouhar,F
通讯作者:
Farouhar,F
DOI:
--
发表时间:
1984
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Fox,RI;Fong,S;Tsoukas,C;Vaughan,JH
通讯作者:
Vaughan,JH
影响因子:
--
作者:
Carol L. Young;T. C. Adamson;J. Vaughan;Robert I. Fox
通讯作者:
Carol L. Young;T. C. Adamson;J. Vaughan;Robert I. Fox
影响因子:
--
作者:
vandeRijn,M;Cleary,ML;Variakojis,D;Warnke,RA;Chang,PP;Kamel,OW
通讯作者:
Kamel,OW
DOI:
--
发表时间:
1985
期刊:
Clinics in rheumatic diseases
影响因子:
--
作者:
Fox,RI;Lotz,M;Rhodes,G;Vaughan,JH
通讯作者:
Vaughan,JH